TOTAL VOLUME:
$154.7b
24H VOL:
$279,496,801
24H TRANSACTIONS:
2,984,640,614
OPEN INTEREST:
$1,923,931,766
416,910
Markets across
40,107
events
MATCHED EVENTS:
4,571
PLATFORM COVERAGE:
5
Polymarket:
37%
VS.
Kalshi:
63%
Closed: Oct 5, 12:17 PM EST
Kalshi
These markets track Eli Lilly's projected credit card spending growth for September 2026, measured against specific thresholds. The outcomes depend on year-over-year changes reported by Carbon Arc, reflecting consumer spending trends through aggregated U.S. transaction data.
All markets resolve based on the Carbon Arc Eli Lilly Monthly Credit Card Spend index for September 2026, comparing it to various thresholds ranging from 96.5 to 173.5. The index measures year-over-year spending changes, where 100 indicates no change from the prior year, values above 100 show growth, and values below indicate decline. Determination for all markets uses the first value reported by Carbon Arc for September 2026, with any subsequent corrections or revisions disregarded once the market is settled. The index is derived from Carbon Arc’s aggregated U.S. credit and debit card transaction panel, matched to the same period of the previous year and updated daily. Kalshi explicitly states it is not affiliated with Eli Lilly, and all trademarks remain property of their respective owners.
This market resolves around Oct 14, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. The final determination will rely on officially released financial data from Eli Lilly, typically published in their standard corporate spending reports. Traders should monitor official announcements and verified financial disclosures leading up to that date to anticipate any last-minute shifts.
Several signals could shift this market before it settles. Key company announcements from Eli Lilly — such as earnings previews, changes in spending policy, or major contractual developments — may influence trader sentiment. Broader economic indicators like consumer confidence reports, changes in interest rates, or sector-wide trends in pharmaceutical industry spending also often affect this type of market. Any unexpected news around the company's financial health or credit operations could cause rapid price adjustments as traders reassess probabilities.